NEW YORK ( TheStreet) -- NuVasive (Nasdaq: NUVA) hit a new 52-week low Tuesday as it is currently trading at $12.25, below its previous 52-week low of $12.27 with 515,148 shares traded as of 3:30 p.m. ET. Average volume has been one million shares over the past 30 days. NuVasive has a market cap of $552.1 million and is part of the health care sector and health services industry. Shares are down 49% year to date as of the close of trading on Monday. NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. Its products are used in applications for spine fusion surgery.
TheStreet Ratings rates NuVasive as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. You can view the full NuVasive Ratings Report. See all 52-week low stocks or get investment ideas from our investment research center.